The present invention provides for a pharmaceutical composition comprising a therapeutically effect amount of {HEAD ~ an isolated peptide} having {TAIL ~ an amino acid sequence} corresponding to the amino acid sequence of a V domain of RAGE and a pharmaceutically acceptable carrier 
having
The present invention provides for a pharmaceutical composition comprising a therapeutically effect amount of { HEAD ~ an isolated peptide } having { TAIL ~ an amino acid sequence } corresponding to the amino acid sequence of a V domain of RAGE and a pharmaceutically acceptable carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH